#38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals.
What you'll get out of this episode:
- Dr. Michael Kyle's Background: Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals.
- Understanding Obesity: A discussion on different types of obesity and the importance of tailored treatments.
- Global Perspectives: Comparing how the U.S. and European countries handle obesity and the lessons to be learned.
- Evolving Treatments: The parallel evolution of hypertension and obesity treatments.
- Behavioral Approaches: The importance of sustainable lifestyle changes and behavior modification in addressing obesity.
To learn more about our guests and their companies:
LinkedIn https://www.linkedin.com/in/michael-l-kyle/
Company LinkedIn https://www.linkedin.com/company/currax-pharmaceuticals-llc/
Website https://www.curraxpharma.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/